Monte Rosa Therapeutics (GLUE) Return on Assets (2023 - 2025)
Historic Return on Assets for Monte Rosa Therapeutics (GLUE) over the last 3 years, with Q3 2025 value amounting to 0.05%.
- Monte Rosa Therapeutics' Return on Assets rose 4100.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 4100.0%. This contributed to the annual value of 0.2% for FY2024, which is N/A changed from last year.
- As of Q3 2025, Monte Rosa Therapeutics' Return on Assets stood at 0.05%, which was up 4100.0% from 0.06% recorded in Q2 2025.
- In the past 5 years, Monte Rosa Therapeutics' Return on Assets registered a high of 0.06% during Q2 2025, and its lowest value of 0.49% during Q4 2023.
- For the 3-year period, Monte Rosa Therapeutics' Return on Assets averaged around 0.23%, with its median value being 0.28% (2024).
- Its Return on Assets has fluctuated over the past 5 years, first skyrocketed by 2900bps in 2024, then soared by 4900bps in 2025.
- Quarter analysis of 3 years shows Monte Rosa Therapeutics' Return on Assets stood at 0.49% in 2023, then surged by 60bps to 0.19% in 2024, then soared by 126bps to 0.05% in 2025.
- Its Return on Assets stands at 0.05% for Q3 2025, versus 0.06% for Q2 2025 and 0.01% for Q1 2025.